China Health Technology (1069) Announces Director Resignation and New Chief Executive Officer

Bulletin Express12-01

China Health Technology Group Holding Company Limited (Stock code: 1069) announced the resignation of Executive Director and Chief Executive Officer, Mr. Wang Yibin, effective 1 December 2025. According to the company, Mr. Wang stepped down due to other business engagements that require more of his time and has confirmed no disagreement with the board or matters needing shareholder attention. The board expressed gratitude for Mr. Wang’s contributions.

Simultaneously, the company appointed Ms. Bu Xue as Chief Executive Officer, effective the same date. Aged 36 and serving as an Executive Director since 1 April 2025, Ms. Bu holds a bachelor’s degree in Business Administration and has over a decade of experience in marketing and business development. She is qualified in accounting and taxation, with an annual remuneration of HK$96,000 for her roles as Executive Director and Chief Executive Officer.

Additionally, Mr. Wang ceased to be a member of the nomination committee of the board from 1 December 2025, and Independent Non-Executive Director Mr. Chau Wing Nam has been appointed to this role. The latest board composition comprises Professor Fei Phillip and Ms. Bu as Executive Directors, and three Independent Non-Executive Directors—including Mr. Chau—overseeing corporate governance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1109399833?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 22:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109399833","market":"us","top_or_hot":-1,"title":"China Health Technology (1069) Announces Director Resignation and New Chief Executive Officer","media":"Bulletin Express","content":"<p>China Health Technology Group Holding Company Limited (Stock code: 1069) announced the resignation of Executive Director and Chief Executive Officer, Mr. Wang Yibin, effective 1 December 2025. According to the company, Mr. Wang stepped down due to other business engagements that require more of his time and has confirmed no disagreement with the board or matters needing shareholder attention. The board expressed gratitude for Mr. Wang’s contributions.</p>\n<p>Simultaneously, the company appointed Ms. Bu Xue as Chief Executive Officer, effective the same date. Aged 36 and serving as an Executive Director since 1 April 2025, Ms. Bu holds a bachelor’s degree in Business Administration and has over a decade of experience in marketing and business development. She is qualified in accounting and taxation, with an annual remuneration of HK$96,000 for her roles as Executive Director and Chief Executive Officer.</p>\n<p>Additionally, Mr. Wang ceased to be a member of the nomination committee of the board from 1 December 2025, and Independent Non-Executive Director Mr. Chau Wing Nam has been appointed to this role. The latest board composition comprises Professor Fei Phillip and Ms. Bu as Executive Directors, and three Independent Non-Executive Directors—including Mr. Chau—overseeing corporate governance.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Health Technology (1069) Announces Director Resignation and New Chief Executive Officer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Health Technology (1069) Announces Director Resignation and New Chief Executive Officer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-01 22:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Health Technology Group Holding Company Limited (Stock code: 1069) announced the resignation of Executive Director and Chief Executive Officer, Mr. Wang Yibin, effective 1 December 2025. According to the company, Mr. Wang stepped down due to other business engagements that require more of his time and has confirmed no disagreement with the board or matters needing shareholder attention. The board expressed gratitude for Mr. Wang’s contributions.</p>\n<p>Simultaneously, the company appointed Ms. Bu Xue as Chief Executive Officer, effective the same date. Aged 36 and serving as an Executive Director since 1 April 2025, Ms. Bu holds a bachelor’s degree in Business Administration and has over a decade of experience in marketing and business development. She is qualified in accounting and taxation, with an annual remuneration of HK$96,000 for her roles as Executive Director and Chief Executive Officer.</p>\n<p>Additionally, Mr. Wang ceased to be a member of the nomination committee of the board from 1 December 2025, and Independent Non-Executive Director Mr. Chau Wing Nam has been appointed to this role. The latest board composition comprises Professor Fei Phillip and Ms. Bu as Executive Directors, and three Independent Non-Executive Directors—including Mr. Chau—overseeing corporate governance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01069","symbol_name":"中国健康科技集团","start_time":0,"source_url":"","article_id":"1109399833","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109399833","pubTimestamp":1764600111,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Health Technology Group Holding Company Limited (Stock code: 1069) announced the resignation of Executive Director and Chief Executive Officer, Mr. Wang Yibin, effective 1 December 2025....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01069":"中国健康科技集团"},"translate_title":"中国健康科技(1069)公布董事辞任及新任行政总裁","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01069":1},"content_text":"China Health Technology Group Holding Company Limited (Stock code: 1069) announced the resignation of Executive Director and Chief Executive Officer, Mr. Wang Yibin, effective 1 December 2025. According to the company, Mr. Wang stepped down due to other business engagements that require more of his time and has confirmed no disagreement with the board or matters needing shareholder attention. The board expressed gratitude for Mr. Wang’s contributions.\nSimultaneously, the company appointed Ms. Bu Xue as Chief Executive Officer, effective the same date. Aged 36 and serving as an Executive Director since 1 April 2025, Ms. Bu holds a bachelor’s degree in Business Administration and has over a decade of experience in marketing and business development. She is qualified in accounting and taxation, with an annual remuneration of HK$96,000 for her roles as Executive Director and Chief Executive Officer.\nAdditionally, Mr. Wang ceased to be a member of the nomination committee of the board from 1 December 2025, and Independent Non-Executive Director Mr. Chau Wing Nam has been appointed to this role. The latest board composition comprises Professor Fei Phillip and Ms. Bu as Executive Directors, and three Independent Non-Executive Directors—including Mr. Chau—overseeing corporate governance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1109399833","isCrawlerRequest":true}